Physician profile
Eric J Springer
NPI 1275976029
$5,223.82
in general payments reported to CMS, 2019-2025
29 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,690 · 2020: $426 · 2022: $32.03 · 2023: $72.18 · 2024: $739 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630 · Travel and Lodging: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.38 |
| Travel and Lodging | $445.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,647.26 | 2019-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter |
| Neotract INC. | $1,212.95 | 2019 | |
| Procept Biorobotics Corporation | $615.70 | 2024 | Aquabeam System |
| Endo Pharmaceuticals INC. | $285.04 | 2019-2020 | |
| Astellas Pharma US INC | $217.01 | 2019-2020 | |
| Calyxo, INC. | $151.91 | 2025 | Cvac Aspiration System |
| Antares Pharma, INC. | $140.05 | 2019-2020 | |
| Janssen Biotech, INC. | $129.62 | 2019-2025 | Tremfya |
| Laborie Medical Technologies Corp. | $122.85 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Abbvie INC. | $110.28 | 2019-2020 | |
| Coloplast Corp | $92.01 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $68.02 | 2019 | |
| Renovia INC | $67.63 | 2019 | |
| Ferring Pharmaceuticals INC. | $61.67 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $38.55 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $36.94 | 2019 | |
| Allergan, INC. | $36.61 | 2019 | |
| Baxter Healthcare | $29.44 | 2019 | |
| Karl Storz Endoscopy-America | $20.78 | 2020 | |
| Travere Therapeutics, INC. | $20.07 | 2019 | |
| Alnylam Pharmaceuticals INC. | $17.22 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $17.06 | 2019 | |
| Amgen INC. | $16.12 | 2019 | |
| Seagen INC. | $16.05 | 2020 | |
| Ethicon US, LLC | $14.82 | 2019 | |
| Metuchen Pharmaceuticals | $14.22 | 2019 | |
| Pfizer INC. | $12.34 | 2019 | |
| Zyla Life Sciences, INC. | $11.60 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Springer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.